scholarly article | Q13442814 |
P50 | author | Soumen Basak | Q60316456 |
P2093 | author name string | Alexander Hoffmann | |
Shannon L Werner | |||
Carl F Ware | |||
Chris A Benedict | |||
Ellen O'Dea | |||
Gourisankar Ghosh | |||
Hana Kim | |||
Inder M Verma | |||
Jeffrey D Kearns | |||
Vinay Tergaonkar | |||
P2860 | cites work | Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines | Q74321402 |
NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100 | Q24290908 | ||
I kappa B: a specific inhibitor of the NF-kappa B transcription factor | Q24296774 | ||
Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers | Q24562579 | ||
Coordination between NF-kappaB family members p50 and p52 is essential for mediating LTbetaR signals in the development and organization of secondary lymphoid tissues | Q24685416 | ||
Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway | Q28214369 | ||
Lymph node fibroblastic reticular cells construct the stromal reticulum via contact with lymphocytes | Q28590628 | ||
Missing pieces in the NF-kappaB puzzle | Q29547864 | ||
The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation | Q29617813 | ||
Identification of novel protein-protein interactions using a versatile mammalian tandem affinity purification expression system | Q30980892 | ||
Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways | Q34173731 | ||
Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism | Q34227912 | ||
Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-kappaB activation pathways | Q34331911 | ||
Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta | Q34331980 | ||
Circuitry of nuclear factor kappaB signaling | Q34514908 | ||
Organogenesis of lymphoid tissues | Q35096187 | ||
Regulation of secondary lymphoid organ development by the nuclear factor-kappaB signal transduction pathway | Q35216951 | ||
The IKK NF-kappa B system: a treasure trove for drug development | Q35621375 | ||
Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology | Q35815962 | ||
Lymphotoxin and LIGHT signaling pathways and target genes | Q35951798 | ||
IkappaBepsilon provides negative feedback to control NF-kappaB oscillations, signaling dynamics, and inflammatory gene expression. | Q36117584 | ||
Requirement for the NF-kappaB family member RelA in the development of secondary lymphoid organs | Q36369876 | ||
The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding | Q36904833 | ||
Genetic analysis of NF- B/Rel transcription factors defines functional specificities | Q39962410 | ||
Stimulus specificity of gene expression programs determined by temporal control of IKK activity | Q40372675 | ||
Receptor-specific signaling for both the alternative and the canonical NF-kappaB activation pathways by NF-kappaB-inducing kinase | Q40504374 | ||
The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways | Q40696432 | ||
Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase | Q40954925 | ||
Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells. | Q40972388 | ||
NF-kappa B precursor p100 inhibits nuclear translocation and DNA binding of NF-kappa B/rel-factors. | Q41537136 | ||
Distinct roles of IkappaB proteins in regulating constitutive NF-kappaB activity. | Q42483415 | ||
Lymphotoxin-beta receptor signaling is required for the homeostatic control of HEV differentiation and function | Q42486404 | ||
The 20S proteasome processes NF-kappaB1 p105 into p50 in a translation-independent manner | Q42703666 | ||
The NF-kappa B activation in lymphotoxin beta receptor signaling depends on the phosphorylation of p65 at serine 536. | Q44207683 | ||
p105.Ikappa Bgamma and prototypical Ikappa Bs use a similar mechanism to bind but a different mechanism to regulate the subcellular localization of NF-kappa B. | Q46026945 | ||
Regulation of naive T cell function by the NF-kappaB2 pathway | Q46071109 | ||
I kappa B gamma, a 70 kd protein identical to the C-terminal half of p110 NF-kappa B: a new member of the I kappa B family | Q46153930 | ||
p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction | Q46602560 | ||
Lymph node genesis is induced by signaling through the lymphotoxin beta receptor | Q47713223 | ||
RelB/p50 Dimers Are Differentially Regulated by Tumor Necrosis Factor-α and Lymphotoxin-β Receptor Activation | Q57093168 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha | Q15325126 |
NF-κB | Q411114 | ||
V-rel reticuloendotheliosis viral oncogene homolog A (avian) | Q15326089 | ||
P304 | page(s) | 369-81 | |
P577 | publication date | 2007-01-26 | |
P1433 | published in | Cell | Q655814 |
P1476 | title | A fourth IkappaB protein within the NF-kappaB signaling module | |
P478 | volume | 128 |
Q39086011 | 30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology |
Q28265343 | A Regulated, Ubiquitin-Independent Degron in IκBα |
Q37273640 | A cell-intrinsic requirement for NF-κB-inducing kinase in CD4 and CD8 T cell memory. |
Q36356398 | A dominant-negative F-box deleted mutant of E3 ubiquitin ligase, β-TrCP1/FWD1, markedly reduces myeloma cell growth and survival in mice |
Q37287436 | A mouse model of pathological small intestinal epithelial cell apoptosis and shedding induced by systemic administration of lipopolysaccharide |
Q37207403 | A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-kappaB family |
Q42244326 | A new role for IKK-α in hepatitis C virus-induced lipogenesis |
Q36957946 | A pathway switch directs BAFF signaling to distinct NFκB transcription factors in maturing and proliferating B cells. |
Q36025311 | A role for the IkappaB family member Bcl-3 in the control of central immunologic tolerance |
Q39764257 | A semi-mechanistic integrated toxicokinetic-toxicodynamic (TK/TD) model for arsenic(III) in hepatocytes |
Q37811890 | A single NFκB system for both canonical and non-canonical signaling |
Q37412660 | A structural guide to proteins of the NF-kappaB signaling module |
Q40589913 | A systemic network triggered by human cytomegalovirus entry. |
Q40799292 | Activation of noncanonical NF-kappaB signaling by the oncoprotein Tio. |
Q35263997 | Alternative nuclear functions for NF-κB family members |
Q91782618 | An NFκB Activity Calculator to Delineate Signaling Crosstalk: Type I and II Interferons Enhance NFκB via Distinct Mechanisms |
Q33882346 | An alternative to lung inflammation and fibrosis |
Q36082780 | An astrocyte-specific proteomic approach to inflammatory responses in experimental rat glaucoma |
Q37325412 | Apoptosis induced by β,β-dimethylacrylshikonin is associated with Bcl-2 and NF-κB in human breast carcinoma MCF-7 cells |
Q35062895 | Autosomal-dominant B-cell deficiency with alopecia due to a mutation in NFKB2 that results in nonprocessable p100. |
Q36198250 | BIRC2/cIAP1 Is a Negative Regulator of HIV-1 Transcription and Can Be Targeted by Smac Mimetics to Promote Reversal of Viral Latency. |
Q36514124 | Balance between NF-κB p100 and p52 regulates T cell costimulation dependence |
Q27300897 | Both functional LTbeta receptor and TNF receptor 2 are required for the development of experimental cerebral malaria |
Q40211722 | Carbon dioxide-dependent regulation of NF-κB family members RelB and p100 gives molecular insight into CO2-dependent immune regulation. |
Q36921618 | Caspase-9b Interacts Directly with cIAP1 to Drive Agonist-Independent Activation of NF-κB and Lung Tumorigenesis |
Q42144467 | Celebrating 25 years of NF-κB research |
Q30583559 | Cell migration to CXCL12 requires simultaneous IKKα and IKKβ-dependent NF-κB signaling |
Q37120661 | Cell-autonomous role for NF-kappa B in immature bone marrow B cells |
Q36119506 | Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-kappaB activation |
Q34352064 | Classical NF-kappaB activation negatively regulates noncanonical NF-kappaB-dependent CXCL12 expression |
Q34109197 | Communicating oscillatory networks: frequency domain analysis. |
Q35018212 | Computational modeling of mammalian signaling networks |
Q37991561 | Consequences of fuzziness in the NFκB/IκBα interaction |
Q36699754 | Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-kappaB pathway and promotes lymphomagenesis |
Q37146086 | Constitutive production of NF-kappaB2 p52 is not tumorigenic but predisposes mice to inflammatory autoimmune disease by repressing Bim expression. |
Q37460813 | Context-specific BAFF-R signaling by the NF-κB and PI3K pathways |
Q28585900 | Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-κB pathways |
Q39547330 | Counteracting effect of TRPC1-associated Ca2+ influx on TNF-α-induced COX-2-dependent prostaglandin E2 production in human colonic myofibroblasts |
Q37178526 | Crosstalk via the NF-kappaB signaling system |
Q33393459 | Differential RelA- and RelB-dependent gene transcription in LTbetaR-stimulated mouse embryonic fibroblasts |
Q41965715 | Differential requirements for IKKalpha and IKKbeta in the differentiation of primary human osteoarthritic chondrocytes. |
Q34428468 | Distinct motifs in the intracellular domain of human CD30 differentially activate canonical and alternative transcription factor NF-κB signaling |
Q51433130 | Double phosphorylation-induced structural changes in the signal-receiving domain of IκBα in complex with NF-κB. |
Q34460275 | ER stress activates NF-κB by integrating functions of basal IKK activity, IRE1 and PERK. |
Q28755808 | Elucidating the function of an ancient NF-kappaB p100 homologue, CrRelish, in antibacterial defense |
Q41881239 | Epigenetic control: slow and global, nimble and local |
Q28828801 | Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein-protein interaction module |
Q34483207 | Expanding role of cyclin dependent kinases in cytokine inducible gene expression. |
Q35919057 | Fbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma |
Q38138557 | Friend or foe: emerging role of nuclear factor kappa-light-chain-enhancer of activated B cells in cell senescence |
Q33795250 | G-protein-coupled-receptor kinases mediate TNFα-induced NFκB signalling via direct interaction with and phosphorylation of IκBα. |
Q28388105 | Gadd45 proteins as critical signal transducers linking NF-kappaB to MAPK cascades |
Q40461023 | Galactomannan Downregulates the Inflammation Responses in Human Macrophages via NFκB2/p100. |
Q24641914 | Generation and activation of multiple dimeric transcription factors within the NF-kappaB signaling system |
Q90006561 | Genome reading by the NF-κB transcription factors |
Q37789516 | High-throughput, single-cell NF-κB dynamics |
Q37948116 | How do pleiotropic kinase hubs mediate specific signaling by TNFR superfamily members? |
Q34384130 | IKK phosphorylates RelB to modulate its promoter specificity and promote fibroblast migration downstream of TNF receptors |
Q35039306 | IKKα is required for the homeostasis of regulatory T cells and for the expansion of both regulatory and effector CD4 T cells. |
Q36015205 | IKKα-mediated signaling circuitry regulates early B lymphopoiesis during hematopoiesis |
Q64248378 | Immune Differentiation Regulator p100 Tunes NF-κB Responses to TNF |
Q27010061 | Immune-pineal axis: nuclear factor κB (NF-kB) mediates the shift in the melatonin source from pinealocytes to immune competent cells |
Q36850404 | Inducible tumor necrosis factor (TNF) receptor-associated factor-1 expression couples the canonical to the non-canonical NF-κB pathway in TNF stimulation |
Q50281561 | Inflammatory responses and inflammation-associated diseases in organs |
Q37376213 | Inhibition of PHLPP2/cyclin D1 protein translation contributes to the tumor suppressive effect of NFκB2 (p100). |
Q34043446 | Inhibitor of NF-kappa B kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis [corrected] |
Q34320072 | Inhibitor of apoptosis proteins (IAPs) and their antagonists regulate spontaneous and tumor necrosis factor (TNF)-induced proinflammatory cytokine and chemokine production |
Q39592545 | Inhibitory effects of chelidonic acid on IL-6 production by blocking NF-κB and caspase-1 in HMC-1 cells |
Q37380130 | Innate immune memory and homeostasis may be conferred through crosstalk between the TLR3 and TLR7 pathways |
Q37305074 | Integrating computational and biochemical studies to explore mechanisms in NF-{kappa}B signaling |
Q28080198 | Interplay of Murine Gammaherpesvirus 68 with NF-kappaB Signaling of the Host |
Q37995679 | It takes two to tango: IκBs, the multifunctional partners of NF-κB. |
Q38941958 | Iterative Modeling Reveals Evidence of Sequential Transcriptional Control Mechanisms |
Q35586204 | IκBβ enhances the generation of the low-affinity NFκB/RelA homodimer. |
Q40757192 | Japanese encephalitis virus utilizes the canonical pathway to activate NF-kappaB but it utilizes the type I interferon pathway to induce major histocompatibility complex class I expression in mouse embryonic fibroblasts. |
Q37239051 | Kinetic control of negative feedback regulators of NF-kappaB/RelA determines their pathogen- and cytokine-receptor signaling specificity |
Q37948123 | LTβR and CD40: working together in dendritic cells to optimize immune responses. |
Q37603373 | Late-phase synthesis of IκBα insulates the TLR4-activated canonical NF-κB pathway from noncanonical NF-κB signaling in macrophages. |
Q27690748 | Lessons from mathematically modeling the NF-κB pathway |
Q35349474 | Loss of c-REL but not NF-κB2 prevents autoimmune disease driven by FasL mutation |
Q37276503 | Loss of estrogen-related receptor α promotes hepatocarcinogenesis development via metabolic and inflammatory disturbances. |
Q33882384 | Loss of negative feedback control of nuclear factor-kappaB2 activity in lymphocytes leads to fatal lung inflammation. |
Q36891038 | Lung tumor NF-κB signaling promotes T cell-mediated immune surveillance |
Q33399367 | Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice |
Q37243919 | Lymphotoxin-mediated crosstalk between B cells and splenic stroma promotes the initial type I interferon response to cytomegalovirus |
Q42109896 | MLN4924 sensitizes monocytes and maturing dendritic cells for TNF-dependent and -independent necroptosis |
Q38182355 | Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies |
Q37670095 | Molecular mechanisms of system control of NF-kappaB signaling by IkappaBalpha |
Q33869955 | Mouse aorta smooth muscle cells differentiate into lymphoid tissue organizer-like cells on combined tumor necrosis factor receptor-1/lymphotoxin beta-receptor NF-kappaB signaling |
Q38066579 | Moving to the core: spatiotemporal analysis of Forkhead box O (FOXO) and nuclear factor-κB (NF-κB) nuclear translocation |
Q27010700 | Multiscale models of cell signaling |
Q36098755 | NEMO ensures signaling specificity of the pleiotropic IKKβ by directing its kinase activity toward IκBα. |
Q92069747 | NF-kB as a key player in regulation of cellular radiation responses and identification of radiation countermeasures |
Q37363042 | NF-kappaB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism |
Q24656611 | NF-kappaB p52:RelB heterodimer recognizes two classes of kappaB sites with two distinct modes |
Q37480036 | NF-kappaB regulation: the nuclear response |
Q37701897 | NF-kappaB signaling: multiple angles to target OA. |
Q42009786 | NF-kappaB2 (p100) limits TNF-alpha-induced osteoclastogenesis |
Q41979732 | NF-κB in T-cell Acute Lymphoblastic Leukemia: Oncogenic Functions in Leukemic and in Microenvironmental Cells. |
Q35808323 | NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma |
Q37777775 | NF-κB inducing kinase: A key regulator in the immune system and in cancer |
Q26859097 | NF-κB regulation: lessons from structures |
Q37691276 | NF-κB signaling |
Q38227386 | NF-κB signaling at the crossroads of inflammation and atherogenesis: searching for new therapeutic links |
Q35147834 | NF-κB signaling participates in both RANKL- and IL-4-induced macrophage fusion: receptor cross-talk leads to alterations in NF-κB pathways. |
Q26822516 | NF-κB, the first quarter-century: remarkable progress and outstanding questions |
Q35570169 | NF-κB–inducing kinase plays an essential T cell–intrinsic role in graft-versus-host disease and lethal autoimmunity in mice |
Q49953053 | NKILA inhibits NF-κB signaling and suppresses tumor metastasis |
Q36080679 | NOS1-derived nitric oxide promotes NF-κB transcriptional activity through inhibition of suppressor of cytokine signaling-1. |
Q38166953 | New paradigms in inflammatory signaling in vascular endothelial cells |
Q34858737 | New regulators of NF-kappaB in inflammation |
Q37948121 | Non-canonical NF-κB signaling activation and regulation: principles and perspectives |
Q37694101 | Non-canonical NFκB mutations reinforce pro-survival TNF response in multiple myeloma through an autoregulatory RelB:p50 NFκB pathway. |
Q39161693 | Noncanonical NF-κB activation by the oncoprotein Tio occurs through a nonconserved TRAF3-binding motif |
Q89011918 | Noncanonical NF-κB in Cancer |
Q54348334 | Nuclear factor κB1/RelA mediates the inflammation and/or survival of human airway exposed to sulfur mustard. |
Q34431075 | Nuclear factor-κB-inducing kinase (NIK) contains an amino-terminal inhibitor of apoptosis (IAP)-binding motif (IBM) that potentiates NIK degradation by cellular IAP1 (c-IAP1). |
Q42227779 | Opposing roles for TRAF1 in the alternative versus classical NF-κB pathway in T cells |
Q57158869 | Platelet-Rich Plasma and Cartilage Repair |
Q92000280 | Preventing abnormal NF-κB activation and autoimmunity by Otub1-mediated p100 stabilization |
Q59799020 | Profiling the proteomic inflammatory state of human astrocytes using DIA mass spectrometry |
Q34722684 | Protein ubiquitination in lymphoid malignancies |
Q46211455 | Proteolysis of NF-kappaB1 p105 is essential for T cell antigen receptor-induced proliferation |
Q35160414 | Proteomic screen reveals Fbw7 as a modulator of the NF-κB pathway. |
Q39192699 | Quantitation of the dynamic profiles of the innate immune response using multiplex selected reaction monitoring-mass spectrometry |
Q33951081 | Quantitative characterization and analysis of the dynamic NF-κB response in microglia |
Q34488853 | Recruitment of RelB to the Csf2 Promoter Enhances RelA-mediated Transcription of Granulocyte-Macrophage Colony-stimulating Factor |
Q37995680 | Regulation of NF-κB by ubiquitination and degradation of the IκBs |
Q61135032 | Regulation of T cell afferent lymphatic migration by targeting LTβR-mediated non-classical NFκB signaling |
Q37579634 | Regulation of TNFRSF and innate immune signalling complexes by TRAFs and cIAPs |
Q39623770 | Regulation of activity and function of the p52 NF-κB subunit following DNA damage |
Q26860148 | Regulation of nuclear factor-κB in autoimmunity |
Q28247029 | RelB, a new partner of aryl hydrocarbon receptor-mediated transcription |
Q33348553 | RelB-dependent stromal cells promote T-cell leukemogenesis |
Q37238291 | RelB: an outlier in leukocyte biology |
Q39995976 | Replication of Theiler's virus requires NF-kappa B-activation: higher viral replication and spreading in astrocytes from susceptible mice |
Q39972789 | Respiratory syncytial virus induces RelA release from cytoplasmic 100-kDa NF-kappa B2 complexes via a novel retinoic acid-inducible gene-I⋅NF- kappa B-inducing kinase signaling pathway |
Q37902868 | Return to homeostasis: downregulation of NF-κB responses |
Q37786156 | Role of NF-κB in the Anti-Inflammatory Effects of Tocotrienols |
Q26852416 | Role of T cell-nuclear factor κB in transplantation |
Q26752576 | Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches |
Q33800318 | Roles of the NF-kappaB pathway in lymphocyte development and function |
Q36033829 | SCF(Fbw7) modulates the NFkB signaling pathway by targeting NFkB2 for ubiquitination and destruction. |
Q38065012 | SCF-mediated degradation of p100 (NF-κB2): mechanisms and relevance in multiple myeloma |
Q33689008 | SHP2 is induced by the HBx-NF-κB pathway and contributes to fibrosis during human early hepatocellular carcinoma development. |
Q38763487 | STC1 promotes cell apoptosis via NF-κB phospho-P65 Ser536 in cervical cancer cells |
Q28118772 | Self-termination of the terminator |
Q36382863 | Signal regulatory protein α regulates the homeostasis of T lymphocytes in the spleen. |
Q91938934 | Signaling Crosstalk Mechanisms That May Fine-Tune Pathogen-Responsive NFκB |
Q35452032 | Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease |
Q38779804 | Signaling via the NFκB system. |
Q92702732 | Single-Cell Analysis of Multiple Steps of Dynamic NF-κB Regulation in Interleukin-1α-Triggered Tumor Cells Using Proximity Ligation Assays |
Q39941007 | Sources of dynamic variability in NF-κB signal transduction: a mechanistic model |
Q39259508 | Stabilization of RelB requires multidomain interactions with p100/p52. |
Q38268527 | Standard and immunoproteasomes show similar peptide degradation specificities. |
Q35608607 | Stimulus-selective crosstalk via the NF-κB signaling system reinforces innate immune response to alleviate gut infection |
Q27667549 | Structural basis of SETD6-mediated regulation of the NF-kB network via methyl-lysine signaling |
Q91711303 | Substrate complex competition is a regulatory motif that allows NFκB RelA to license but not amplify NFκB RelB |
Q28513770 | Suppression of LPS-induced TNF-alpha production in macrophages by cAMP is mediated by PKA-AKAP95-p105 |
Q42050158 | Sustained NF-kappaB activation produces a short-term cell proliferation block in conjunction with repressing effectors of cell cycle progression controlled by E2F or FoxM1. |
Q30591520 | Systematic parameter estimation in data-rich environments for cell signalling dynamics |
Q42709660 | Systems approaches to modeling chronic mucosal inflammation. |
Q37103538 | Systems biology approaches to dissect mammalian innate immunity |
Q36020084 | TGF-beta and tumors--an ill-fated alliance |
Q37036149 | TLR-mediated albuminuria needs TNFα-mediated cooperativity between TLRs present in hematopoietic tissues and CD80 present on non-hematopoietic tissues in mice. |
Q39237606 | TNF Receptor-Associated Factor 1 is a Major Target of Soluble TWEAK. |
Q50130549 | TNF receptor-activated factor 2 mediates cardiac protection through noncanonical NF-κB signaling |
Q37236581 | TNFR2 expression by CD4 effector T cells is required to induce full-fledged experimental colitis |
Q58795144 | TNFSF14/LIGHT, a Non-Canonical NF-κB Stimulus, Induces the HIF Pathway |
Q24300996 | TRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptor |
Q24301176 | TRIM protein-mediated regulation of inflammatory and innate immune signaling and its association with antiretroviral activity |
Q35759267 | Targeting signaling factors for degradation, an emerging mechanism for TRAF functions |
Q37672294 | The NF-kappaB family of transcription factors and its regulation |
Q55657825 | The NF-κB Activating Pathways in Multiple Myeloma. |
Q45961397 | The NF-κB subunit RelB controls p100 processing by competing with the kinases NIK and IKK1 for binding to p100. |
Q34206845 | The Nfkb1 and Nfkb2 proteins p105 and p100 function as the core of high-molecular-weight heterogeneous complexes |
Q38293742 | The RelA/cRel nuclear factor-κB (NF-κB) dimer, crucial for inflammation resolution, mediates the transcription of the key enzyme in melatonin synthesis in RAW 264.7 macrophages |
Q33953115 | The TRAF3 adaptor protein drives proliferation of anaplastic large cell lymphoma cells by regulating multiple signaling pathways |
Q26748938 | The Ubiquitination of NF-κB Subunits in the Control of Transcription |
Q36205234 | The canonical NF-κB pathway differentially protects normal and human tumor cells from ROS-induced DNA damage |
Q37700164 | The complicated role of NF-kappaB in T-cell selection. |
Q26782229 | The cybernetics of TNF: Old views and newer ones |
Q34030580 | The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation. |
Q33685419 | The regulatory logic of the NF-kappaB signaling system |
Q36955377 | The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis |
Q39587742 | The specificity of innate immune responses is enforced by repression of interferon response elements by NF-κB p50 |
Q53674487 | Toll-like receptor 4 is involved in bacterial endotoxin-induced endothelial cell injury and SOC-mediated calcium regulation. |
Q37347235 | Tonic B cell antigen receptor signals supply an NF-kappaB substrate for prosurvival BLyS signaling. |
Q38503829 | Topology, dynamics, and heterogeneity in immune signaling |
Q37622051 | Transcriptional control of the inflammatory response |
Q42579520 | Tumor-suppressor NFκB2 p100 interacts with ERK2 and stabilizes PTEN mRNA via inhibition of miR-494 |
Q41891688 | UV as an amplifier rather than inducer of NF-kappaB activity |
Q28274205 | Ubiquitination and degradation of the inhibitors of NF-kappaB |
Q39045822 | Understanding NF-kappaB signaling via mathematical modeling |
Q41137496 | Visualization of RelB expression and activation at the single-cell level during dendritic cell maturation in Relb-Venus knock-in mice |
Q34526403 | p100/IκBδ sequesters and inhibits NF-κB through kappaBsome formation |
Search more.